This call for proposals includes 31 research funding organisations from the further 23 countries (therein 6 regions): Belgium, Canada (Quebec), Croatia, Denmark, Egypt, Finland, France, Germany (Saxon), Greece, Hungary, Ireland, Israel, Italy (Lombardy, Tuscany), Latvia, Luxemburg, Norway, Panama, Poland, Romania, Slovenia, Spain (Catalonia, Navarre), Sweden and Turkey. The available budget for this call is 24.6 million Euro approximately.
Proposals must be interdisciplinary and clearly demonstrate the potential impact on Personalised Medicine as well as the added value of transnational collaboration.
The ERA PerMed JTC2020 comprises three Research Areas:
Each project proposal must address at least one module of Research Area 3 and at least one module of Research Area 1 or 2. The coherent integration and combination of the different Research Areas and Modules in the proposals will be part of the evaluation process.
Joint research proposals may be submitted by applicants belonging to one of the following categories, if eligible according to relevant regional/national funding organisations’ regulations for research funding:
A. Academia or research institutes;
B. Clinical/public health sector;
C. (Industry) Private partners, e.g. SMEs.
Only transnational projects will be funded. Each consortium submitting a proposal must involve at least three partners eligible for funding coming from three different countries whose funders participate to the call. All three legal entities must be independent of each other. At least two partners of the consortium must be from two different EU Member States or Associated Countries. The maximum number of partners per project is six although no more than 2 eligible partners from the same country participating in the call will be accepted in one consortium (including those partners with own funding).
Partners not eligible to be funded (e.g. from non-funding countries or not fundable according to regional/national regulations of the participating funding organisation) may participate in transnational projects if they are able to secure their own funding. They are considered as full partners and have to be integrated in the pre- and full-proposal templates as such. No more than one partner with its own funding is allowed in consortia with at least three partners eligible for funding. The coordinator must be eligible to be funded by the participating funding organisations to this call.
At the full-proposal stage, a consortium may be expanded up to seven partners in total only by inclusion of a partner from an underrepresented country. A list of underrepresented countries will be provided to coordinators invited to submit full-proposals.
Funding will be awarded for a maximum of three years. ANR will exclusively fund French partners of the selected projects.
Specific annexes for French partners are available on this site. The call text, the instructions and the pre-proposal template are available on this page or/and on the ERA PerMed website (www.erapermed.eu).
The completed application form must be submitted electronically on https://ptoutline.eu/app/erapermed2020
Proposals cannot be submitted to ANR directly.
For any information, please contact, preferably by e-mail:
ANR contact :
More details: www.erapermed.eu